These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22396515)

  • 1. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.
    Bhasin S; Travison TG; Storer TW; Lakshman K; Kaushik M; Mazer NA; Ngyuen AH; Davda MN; Jara H; Aakil A; Anderson S; Knapp PE; Hanka S; Mohammed N; Daou P; Miciek R; Ulloor J; Zhang A; Brooks B; Orwoll K; Hede-Brierley L; Eder R; Elmi A; Bhasin G; Collins L; Singh R; Basaria S
    JAMA; 2012 Mar; 307(9):931-9. PubMed ID: 22396515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 5α-reductase inhibition in men receiving testosterone replacement therapy.
    Gruntmanis U
    JAMA; 2012 Mar; 307(9):968-70. PubMed ID: 22396520
    [No Abstract]   [Full Text] [Related]  

  • 3. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
    Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
    J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
    Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
    Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
    J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5α-reductase type 1 modulates insulin sensitivity in men.
    Upreti R; Hughes KA; Livingstone DE; Gray CD; Minns FC; Macfarlane DP; Marshall I; Stewart LH; Walker BR; Andrew R
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1397-406. PubMed ID: 24823464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
    Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
    Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen.
    Gava G; Armillotta F; Pillastrini P; Giagio S; Alvisi S; Mancini I; Morselli PG; Seracchioli R; Meriggiola MC
    J Sex Med; 2021 Mar; 18(3):646-655. PubMed ID: 33531255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.
    Borst SE; Yarrow JF; Conover CF; Nseyo U; Meuleman JR; Lipinska JA; Braith RW; Beck DT; Martin JS; Morrow M; Roessner S; Beggs LA; McCoy SC; Cannady DF; Shuster JJ
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E433-42. PubMed ID: 24326421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.
    Amory JK; Wang C; Swerdloff RS; Anawalt BD; Matsumoto AM; Bremner WJ; Walker SE; Haberer LJ; Clark RV
    J Clin Endocrinol Metab; 2007 May; 92(5):1659-65. PubMed ID: 17299062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.
    Clark RV; Hermann DJ; Cunningham GR; Wilson TH; Morrill BB; Hobbs S
    J Clin Endocrinol Metab; 2004 May; 89(5):2179-84. PubMed ID: 15126539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
    Tindall DJ; Rittmaster RS
    J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
    Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutasteride: a potent dual inhibitor of 5-alpha-reductase for benign prostatic hyperplasia.
    Rabasseda X
    Drugs Today (Barc); 2004 Aug; 40(8):649-61. PubMed ID: 15510237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
    Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle.
    Bhasin S; Woodhouse L; Casaburi R; Singh AB; Mac RP; Lee M; Yarasheski KE; Sinha-Hikim I; Dzekov C; Dzekov J; Magliano L; Storer TW
    J Clin Endocrinol Metab; 2005 Feb; 90(2):678-88. PubMed ID: 15562020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.
    Amory JK; Anawalt BD; Matsumoto AM; Page ST; Bremner WJ; Wang C; Swerdloff RS; Clark RV
    J Urol; 2008 Jun; 179(6):2333-8. PubMed ID: 18423697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.